| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.27e-05 | 560 | 40 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.30e-05 | 562 | 40 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.37e-05 | 566 | 40 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.89e-05 | 303 | 40 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MYT1L CCAR1 GIGYF2 NCOA6 MAML2 ARID1A NKX2-1 JMJD1C YTHDF3 ZMYND8 TNRC6A | 5.02e-05 | 1356 | 40 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MYT1L CCAR1 NCOA6 MAML2 ARID1A NKX2-1 JMJD1C YTHDF3 ZMYND8 TNRC6A | 7.20e-05 | 1160 | 40 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | poly(G) binding | 1.74e-04 | 10 | 40 | 2 | GO:0034046 | |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 3.51e-04 | 14 | 40 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.61e-04 | 1412 | 40 | 10 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 4.69e-04 | 1459 | 40 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.11e-03 | 34 | 40 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.11e-03 | 34 | 40 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 2.49e-03 | 37 | 40 | 2 | GO:0070717 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 2.77e-03 | 39 | 40 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.62e-03 | 753 | 40 | 6 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PAXIP1 MYT1L POU3F2 NCOA6 RORB MAML2 VEZF1 MGA ATXN1 NKX2-1 LMX1B TFDP2 ZMYND8 THAP11 | 2.34e-07 | 1390 | 41 | 14 | GO:0045944 |
| GeneOntologyCellularComponent | chromatin | MYT1L HLX POU3F2 RORB ARID1A MGA NKX2-1 LMX1B JMJD1C TFDP2 ZMYND8 THAP11 | 1.74e-05 | 1480 | 41 | 12 | GO:0000785 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.74e-04 | 269 | 41 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.36e-04 | 287 | 41 | 5 | GO:0035770 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.45e-04 | 12 | 41 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PAXIP1 NCOA6 ARID1A MGA INTS7 UBAP2L JMJD1C TFDP2 CDK19 THAP11 | 2.54e-04 | 1377 | 41 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.29e-04 | 75 | 41 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 8.82e-04 | 96 | 41 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.01e-03 | 596 | 41 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | P-body | 1.05e-03 | 102 | 41 | 3 | GO:0000932 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.24e-03 | 108 | 41 | 3 | GO:0034708 | |
| HumanPheno | Abnormally increased volition | MYT1L GIGYF2 RORB ARID1A NKX2-1 UBAP2L JMJD1C POLG RAI1 CDK19 SCAF4 | 3.33e-05 | 869 | 18 | 11 | HP:5200263 |
| HumanPheno | Bulbous nose | 4.37e-05 | 201 | 18 | 6 | HP:0000414 | |
| HumanPheno | Diagnostic behavioral phenotype | MYT1L GIGYF2 ARID1A NKX2-1 UBAP2L JMJD1C POLG RAI1 CDK19 SCAF4 | 6.20e-05 | 747 | 18 | 10 | HP:0025783 |
| HumanPheno | Polyembolokoilamania | 1.17e-04 | 5 | 18 | 2 | HP:0032508 | |
| HumanPheno | Disinhibition | MYT1L GIGYF2 RORB ARID1A NKX2-1 UBAP2L JMJD1C RAI1 CDK19 SCAF4 | 1.22e-04 | 807 | 18 | 10 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MYT1L GIGYF2 RORB ARID1A NKX2-1 UBAP2L JMJD1C RAI1 CDK19 SCAF4 | 1.22e-04 | 807 | 18 | 10 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MYT1L GIGYF2 RORB ARID1A NKX2-1 UBAP2L JMJD1C RAI1 CDK19 SCAF4 | 1.22e-04 | 807 | 18 | 10 | HP:5200123 |
| HumanPheno | Social disinhibition | MYT1L GIGYF2 RORB ARID1A NKX2-1 UBAP2L JMJD1C RAI1 CDK19 SCAF4 | 1.22e-04 | 807 | 18 | 10 | HP:5200029 |
| HumanPheno | Aggressive behavior | 1.83e-04 | 516 | 18 | 8 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.83e-04 | 516 | 18 | 8 | HP:0006919 | |
| HumanPheno | Abnormal motivation | MYT1L GIGYF2 RORB ARID1A ATXN1 NKX2-1 UBAP2L JMJD1C POLG RAI1 CDK19 SCAF4 | 2.07e-04 | 1263 | 18 | 12 | HP:5200275 |
| HumanPheno | Abnormal volitional state | MYT1L GIGYF2 RORB ARID1A ATXN1 NKX2-1 UBAP2L JMJD1C POLG RAI1 CDK19 SCAF4 | 2.07e-04 | 1263 | 18 | 12 | HP:0025780 |
| HumanPheno | Abnormal nasal tip morphology | 2.08e-04 | 386 | 18 | 7 | HP:0000436 | |
| HumanPheno | Abnormal social development | MYT1L GIGYF2 RORB ARID1A NKX2-1 UBAP2L JMJD1C RAI1 CDK19 SCAF4 | 3.38e-04 | 908 | 18 | 10 | HP:0025732 |
| MousePheno | abnormal spongiotrophoblast size | 4.51e-05 | 28 | 35 | 3 | MP:0012097 | |
| MousePheno | perinatal lethality | MYT1L LAMA2 HLX GIGYF2 NCOA6 ARID1A VEZF1 NKX2-1 LMX1B NRK THAP11 | 6.23e-05 | 1130 | 35 | 11 | MP:0002081 |
| MousePheno | abnormal neuron number | 1.14e-04 | 456 | 35 | 7 | MP:0008946 | |
| MousePheno | abnormal trophoblast layer morphology | 1.68e-04 | 211 | 35 | 5 | MP:0005031 | |
| MousePheno | increased spongiotrophoblast size | 1.69e-04 | 8 | 35 | 2 | MP:0012098 | |
| MousePheno | abnormal hepatic diverticulum morphology | 1.69e-04 | 8 | 35 | 2 | MP:0012234 | |
| MousePheno | abnormal liver bud morphology | 1.69e-04 | 8 | 35 | 2 | MP:0012235 | |
| MousePheno | abnormal hypothalamus morphology | 1.77e-04 | 44 | 35 | 3 | MP:0000837 | |
| MousePheno | decreased aggression | 3.09e-04 | 53 | 35 | 3 | MP:0005656 | |
| Domain | Homeobox_CS | 7.23e-04 | 186 | 41 | 4 | IPR017970 | |
| Domain | Homeobox | 1.69e-03 | 234 | 41 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.74e-03 | 236 | 41 | 4 | PS00027 | |
| Domain | HOX | 1.77e-03 | 237 | 41 | 4 | SM00389 | |
| Domain | Homeobox_dom | 1.83e-03 | 239 | 41 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.83e-03 | 239 | 41 | 4 | PS50071 | |
| Domain | - | 3.36e-03 | 283 | 41 | 4 | 1.10.10.60 | |
| Domain | Homeodomain-like | 5.92e-03 | 332 | 41 | 4 | IPR009057 | |
| Domain | p53-like_TF_DNA-bd | 6.04e-03 | 53 | 41 | 2 | IPR008967 | |
| Domain | Ser/Thr_kinase_AS | 7.61e-03 | 357 | 41 | 4 | IPR008271 | |
| Domain | S_TKc | 7.76e-03 | 359 | 41 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 7.99e-03 | 362 | 41 | 4 | PS00108 | |
| Domain | UBA-like | 8.70e-03 | 64 | 41 | 2 | IPR009060 | |
| Domain | Pkinase | 9.52e-03 | 381 | 41 | 4 | PF00069 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.49e-05 | 29 | 34 | 3 | M48076 | |
| Pubmed | PAXIP1 CCAR1 GIGYF2 NCOA6 PATL1 EIF3H ARID1A VEZF1 MGA ATXN1 UBAP2L JMJD1C YTHDF3 TFDP2 SCAF4 ZMYND8 TNRC6A THAP11 | 8.25e-15 | 1429 | 41 | 18 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CCAR1 GIGYF2 NCOA6 ARID1A VEZF1 MGA UBAP2L JMJD1C YTHDF3 RAI1 SCAF4 ZMYND8 | 6.44e-10 | 954 | 41 | 12 | 36373674 |
| Pubmed | 8.59e-10 | 268 | 41 | 8 | 33640491 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | AAK1 CCAR1 GIGYF2 PATL1 EIF3H MGA BMP2K UBAP2L YTHDF3 TNRC6A | 9.00e-09 | 724 | 41 | 10 | 36232890 |
| Pubmed | MYT1L CCAR1 EIF3H ARID1A VEZF1 MGA ATXN1 NKX2-1 TFDP2 ZMYND8 | 2.53e-08 | 808 | 41 | 10 | 20412781 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.68e-07 | 351 | 41 | 7 | 38297188 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PAXIP1 CCAR1 NCOA6 ARID1A VEZF1 MGA INTS7 JMJD1C RAI1 SCAF4 ZMYND8 | 2.05e-07 | 1294 | 41 | 11 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.37e-07 | 774 | 41 | 9 | 15302935 | |
| Pubmed | PAXIP1 CCAR1 NCOA6 ARID1A VEZF1 JMJD1C RAI1 SCAF4 ZMYND8 THAP11 | 4.53e-07 | 1103 | 41 | 10 | 34189442 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 5.28e-07 | 134 | 41 | 5 | 25452129 | |
| Pubmed | 6.27e-07 | 57 | 41 | 4 | 21368052 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 8.96e-07 | 908 | 41 | 9 | 19274049 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 9.92e-07 | 670 | 41 | 8 | 22990118 | |
| Pubmed | 1.07e-06 | 65 | 41 | 4 | 26655900 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23358112 | ||
| Pubmed | Family-wide Structural Analysis of Human Numb-Associated Protein Kinases. | 1.36e-06 | 2 | 41 | 2 | 26853940 | |
| Pubmed | 2.23e-06 | 78 | 41 | 4 | 28611094 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.52e-06 | 184 | 41 | 5 | 32908313 | |
| Pubmed | 2.65e-06 | 23 | 41 | 3 | 9225980 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.86e-06 | 341 | 41 | 6 | 32971831 | |
| Pubmed | 3.32e-06 | 549 | 41 | 7 | 38280479 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.48e-06 | 1105 | 41 | 9 | 35748872 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.92e-06 | 583 | 41 | 7 | 29844126 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 6.68e-06 | 1489 | 41 | 10 | 28611215 | |
| Pubmed | 6.72e-06 | 225 | 41 | 5 | 12168954 | ||
| Pubmed | AAK1 CCAR1 PPP1R18 EIF3H VEZF1 BMP2K INTS7 SCAF4 ZMYND8 TNRC6A | 7.00e-06 | 1497 | 41 | 10 | 31527615 | |
| Pubmed | 7.85e-06 | 107 | 41 | 4 | 30995489 | ||
| Pubmed | Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. | 8.12e-06 | 4 | 41 | 2 | 24243019 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 26951672 | ||
| Pubmed | 9.56e-06 | 242 | 41 | 5 | 34011540 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.36e-05 | 123 | 41 | 4 | 26912792 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.52e-05 | 457 | 41 | 6 | 32344865 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.61e-05 | 462 | 41 | 6 | 31138677 | |
| Pubmed | 1.70e-05 | 130 | 41 | 4 | 19386638 | ||
| Pubmed | Cortical RORβ is required for layer 4 transcriptional identity and barrel integrity. | 2.03e-05 | 6 | 41 | 2 | 32851975 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 31758944 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.44e-05 | 1038 | 41 | 8 | 26673895 | |
| Pubmed | 2.51e-05 | 1371 | 41 | 9 | 36244648 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 23535175 | ||
| Pubmed | Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. | 2.84e-05 | 7 | 41 | 2 | 8325628 | |
| Pubmed | 3.44e-05 | 529 | 41 | 6 | 14621295 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 17178841 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.99e-05 | 807 | 41 | 7 | 22681889 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 4.72e-05 | 59 | 41 | 3 | 28813667 | |
| Pubmed | Molecular basis for GIGYF-Me31B complex assembly in 4EHP-mediated translational repression. | 4.86e-05 | 9 | 41 | 2 | 31439631 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.05e-05 | 180 | 41 | 4 | 35198878 | |
| Pubmed | 6.31e-05 | 65 | 41 | 3 | 22496869 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 12051813 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 36613751 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 34614421 | ||
| Pubmed | Streamlined analysis schema for high-throughput identification of endogenous protein complexes. | 8.22e-05 | 71 | 41 | 3 | 20133760 | |
| Pubmed | Thalamocortical axons regulate neurogenesis and laminar fates in the early sensory cortex. | 8.88e-05 | 12 | 41 | 2 | 35613048 | |
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 8.88e-05 | 12 | 41 | 2 | 27824329 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 9.64e-05 | 203 | 41 | 4 | 22083510 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.02e-04 | 398 | 41 | 5 | 35016035 | |
| Pubmed | 1.05e-04 | 77 | 41 | 3 | 21525287 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 1.05e-04 | 13 | 41 | 2 | 17761849 | |
| Pubmed | Intersectional Strategies for Targeting Amacrine and Ganglion Cell Types in the Mouse Retina. | 1.05e-04 | 13 | 41 | 2 | 30186122 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 30705426 | ||
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 35289744 | ||
| Pubmed | Selection system for genes encoding nuclear-targeted proteins. | 1.22e-04 | 14 | 41 | 2 | 9853615 | |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.26e-04 | 82 | 41 | 3 | 31073041 | |
| Pubmed | 1.29e-04 | 418 | 41 | 5 | 34709266 | ||
| Pubmed | 1.31e-04 | 83 | 41 | 3 | 28794006 | ||
| Pubmed | Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. | 1.41e-04 | 15 | 41 | 2 | 18255031 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 22951639 | ||
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 17925232 | ||
| Pubmed | Intersectional mapping of multi-transmitter neurons and other cell types in the brain. | 1.61e-04 | 16 | 41 | 2 | 35793636 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 24368734 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.70e-04 | 444 | 41 | 5 | 34795231 | |
| Pubmed | Fezl is required for the birth and specification of corticospinal motor neurons. | 1.82e-04 | 17 | 41 | 2 | 16157277 | |
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 26180087 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 2.05e-04 | 18 | 41 | 2 | 17500065 | |
| Pubmed | Adult mouse cortical cell taxonomy revealed by single cell transcriptomics. | 2.05e-04 | 18 | 41 | 2 | 26727548 | |
| Pubmed | Stem cell competition driven by the Axin2-p53 axis controls brain size during murine development. | 2.05e-04 | 18 | 41 | 2 | 37054704 | |
| Pubmed | 2.06e-04 | 733 | 41 | 6 | 34672954 | ||
| Pubmed | 2.14e-04 | 98 | 41 | 3 | 34943047 | ||
| Pubmed | 2.19e-04 | 469 | 41 | 5 | 27634302 | ||
| Pubmed | 2.26e-04 | 472 | 41 | 5 | 38943005 | ||
| Pubmed | 2.49e-04 | 1084 | 41 | 7 | 11544199 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 2.54e-04 | 20 | 41 | 2 | 29785026 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 19047629 | ||
| Pubmed | Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. | 2.54e-04 | 20 | 41 | 2 | 12130536 | |
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 2.54e-04 | 20 | 41 | 2 | 11859196 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 34220450 | ||
| Pubmed | 2.55e-04 | 104 | 41 | 3 | 10470851 | ||
| Pubmed | 2.60e-04 | 263 | 41 | 4 | 34702444 | ||
| Pubmed | Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system. | 2.81e-04 | 21 | 41 | 2 | 28880149 | |
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 19596656 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.86e-04 | 497 | 41 | 5 | 36774506 | |
| Pubmed | 2.98e-04 | 1116 | 41 | 7 | 31753913 | ||
| Pubmed | 3.03e-04 | 274 | 41 | 4 | 34244482 | ||
| Pubmed | The Epigenetic State of PRDM16-Regulated Enhancers in Radial Glia Controls Cortical Neuron Position. | 3.09e-04 | 22 | 41 | 2 | 29779941 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 3.09e-04 | 22 | 41 | 2 | 26886794 | |
| Pubmed | 3.34e-04 | 281 | 41 | 4 | 24163370 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 26659141 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 28811219 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.43e-04 | 283 | 41 | 4 | 30585729 | |
| Pubmed | 3.68e-04 | 24 | 41 | 2 | 18635606 | ||
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 39271675 | ||
| Interaction | SMG7 interactions | 1.25e-08 | 319 | 41 | 9 | int:SMG7 | |
| Interaction | CNOT9 interactions | 3.83e-07 | 231 | 41 | 7 | int:CNOT9 | |
| Interaction | SMC5 interactions | CCAR1 GIGYF2 NCOA6 ARID1A VEZF1 MGA UBAP2L JMJD1C YTHDF3 RAI1 SCAF4 ZMYND8 | 4.33e-07 | 1000 | 41 | 12 | int:SMC5 |
| Interaction | TNRC6A interactions | 1.39e-06 | 280 | 41 | 7 | int:TNRC6A | |
| Interaction | GIGYF1 interactions | 1.47e-06 | 177 | 41 | 6 | int:GIGYF1 | |
| Interaction | CNOT2 interactions | 1.52e-06 | 178 | 41 | 6 | int:CNOT2 | |
| Interaction | ALG13 interactions | 1.78e-06 | 183 | 41 | 6 | int:ALG13 | |
| Interaction | SP7 interactions | 2.40e-06 | 304 | 41 | 7 | int:SP7 | |
| Interaction | KLF5 interactions | 2.58e-06 | 195 | 41 | 6 | int:KLF5 | |
| Interaction | FEV interactions | 3.25e-06 | 203 | 41 | 6 | int:FEV | |
| Interaction | TBXT interactions | 3.68e-06 | 116 | 41 | 5 | int:TBXT | |
| Interaction | TOP2A interactions | 8.40e-06 | 520 | 41 | 8 | int:TOP2A | |
| Interaction | TOP1 interactions | 8.63e-06 | 696 | 41 | 9 | int:TOP1 | |
| Interaction | TLE3 interactions | 9.69e-06 | 376 | 41 | 7 | int:TLE3 | |
| Interaction | CPEB1 interactions | 1.13e-05 | 146 | 41 | 5 | int:CPEB1 | |
| Interaction | PRRC2B interactions | 1.49e-05 | 265 | 41 | 6 | int:PRRC2B | |
| Interaction | UNK interactions | 1.64e-05 | 408 | 41 | 7 | int:UNK | |
| Interaction | NUP35 interactions | 2.10e-05 | 424 | 41 | 7 | int:NUP35 | |
| Interaction | DCP1A interactions | 2.10e-05 | 166 | 41 | 5 | int:DCP1A | |
| Interaction | AR interactions | PAXIP1 CCAR1 NCOA6 ARID1A MGA ATXN1 UBAP2L JMJD1C RAI1 ZMYND8 | 2.22e-05 | 992 | 41 | 10 | int:AR |
| Interaction | TOP3B interactions | PAXIP1 NCOA6 PATL1 ARID1A IER5L LMX1B UBAP2L POLG YTHDF3 RAI1 ITPR2 THAP11 | 2.34e-05 | 1470 | 41 | 12 | int:TOP3B |
| Interaction | CELF1 interactions | 2.39e-05 | 288 | 41 | 6 | int:CELF1 | |
| Interaction | EGR2 interactions | 2.43e-05 | 171 | 41 | 5 | int:EGR2 | |
| Interaction | SMG5 interactions | 2.53e-05 | 84 | 41 | 4 | int:SMG5 | |
| Interaction | R3HDM1 interactions | 2.53e-05 | 84 | 41 | 4 | int:R3HDM1 | |
| Interaction | QPRT interactions | 2.53e-05 | 84 | 41 | 4 | int:QPRT | |
| Interaction | HCFC1 interactions | 2.63e-05 | 293 | 41 | 6 | int:HCFC1 | |
| Interaction | CEBPA interactions | PAXIP1 CCAR1 NCOA6 ARID1A VEZF1 INTS7 JMJD1C RAI1 SCAF4 ZMYND8 THAP11 | 2.71e-05 | 1245 | 41 | 11 | int:CEBPA |
| Interaction | TEAD1 interactions | 2.79e-05 | 176 | 41 | 5 | int:TEAD1 | |
| Interaction | FUBP3 interactions | 2.84e-05 | 297 | 41 | 6 | int:FUBP3 | |
| Interaction | EIF4ENIF1 interactions | 3.00e-05 | 300 | 41 | 6 | int:EIF4ENIF1 | |
| Interaction | ZFP36 interactions | 3.19e-05 | 181 | 41 | 5 | int:ZFP36 | |
| Interaction | LHX3 interactions | 3.54e-05 | 185 | 41 | 5 | int:LHX3 | |
| Interaction | YTHDF2 interactions | 3.74e-05 | 312 | 41 | 6 | int:YTHDF2 | |
| Interaction | ZYX interactions | 5.02e-05 | 329 | 41 | 6 | int:ZYX | |
| Interaction | MED27 interactions | 5.42e-05 | 102 | 41 | 4 | int:MED27 | |
| Interaction | HDAC1 interactions | GIGYF2 ARID1A MGA ATXN1 NKX2-1 JMJD1C RAI1 ZMYND8 TNRC6A THAP11 | 5.69e-05 | 1108 | 41 | 10 | int:HDAC1 |
| Interaction | CNOT3 interactions | 6.04e-05 | 207 | 41 | 5 | int:CNOT3 | |
| Interaction | SSRP1 interactions | 6.05e-05 | 685 | 41 | 8 | int:SSRP1 | |
| Interaction | PHF21A interactions | 6.33e-05 | 343 | 41 | 6 | int:PHF21A | |
| Interaction | NFIC interactions | 6.47e-05 | 210 | 41 | 5 | int:NFIC | |
| Interaction | ZC3H7A interactions | 7.23e-05 | 215 | 41 | 5 | int:ZC3H7A | |
| Interaction | PAX8 interactions | 7.54e-05 | 111 | 41 | 4 | int:PAX8 | |
| Interaction | PML interactions | 8.64e-05 | 933 | 41 | 9 | int:PML | |
| Interaction | TP53BP1 interactions | 8.96e-05 | 533 | 41 | 7 | int:TP53BP1 | |
| Interaction | ANKRD17 interactions | 9.15e-05 | 226 | 41 | 5 | int:ANKRD17 | |
| Interaction | MARF1 interactions | 1.31e-04 | 128 | 41 | 4 | int:MARF1 | |
| Interaction | R3HDM2 interactions | 1.35e-04 | 129 | 41 | 4 | int:R3HDM2 | |
| Interaction | PAX9 interactions | 1.39e-04 | 130 | 41 | 4 | int:PAX9 | |
| Interaction | KMT2B interactions | 1.39e-04 | 130 | 41 | 4 | int:KMT2B | |
| Interaction | MED15 interactions | 1.43e-04 | 131 | 41 | 4 | int:MED15 | |
| Interaction | CRX interactions | 1.58e-04 | 254 | 41 | 5 | int:CRX | |
| Interaction | ESRRB interactions | 1.83e-04 | 262 | 41 | 5 | int:ESRRB | |
| Interaction | CNOT10 interactions | 1.90e-04 | 141 | 41 | 4 | int:CNOT10 | |
| Interaction | TPRX2 interactions | 2.01e-04 | 56 | 41 | 3 | int:TPRX2 | |
| Interaction | NCOA6 interactions | 2.12e-04 | 145 | 41 | 4 | int:NCOA6 | |
| Interaction | DAZL interactions | 2.12e-04 | 145 | 41 | 4 | int:DAZL | |
| Interaction | LIMA1 interactions | 2.15e-04 | 429 | 41 | 6 | int:LIMA1 | |
| Interaction | NCOA1 interactions | 2.17e-04 | 146 | 41 | 4 | int:NCOA1 | |
| Interaction | HNF4A interactions | 2.29e-04 | 275 | 41 | 5 | int:HNF4A | |
| Interaction | TNRC6B interactions | 2.57e-04 | 282 | 41 | 5 | int:TNRC6B | |
| Interaction | AGO3 interactions | 2.60e-04 | 153 | 41 | 4 | int:AGO3 | |
| Interaction | PUM1 interactions | 2.79e-04 | 287 | 41 | 5 | int:PUM1 | |
| Interaction | RBBP5 interactions | 2.79e-04 | 287 | 41 | 5 | int:RBBP5 | |
| Interaction | CPEB4 interactions | 2.80e-04 | 156 | 41 | 4 | int:CPEB4 | |
| Interaction | YAP1 interactions | 2.89e-04 | 1095 | 41 | 9 | int:YAP1 | |
| Interaction | PAN3 interactions | 3.13e-04 | 65 | 41 | 3 | int:PAN3 | |
| Interaction | CNOT4 interactions | 3.13e-04 | 65 | 41 | 3 | int:CNOT4 | |
| Interaction | EDC3 interactions | 3.16e-04 | 161 | 41 | 4 | int:EDC3 | |
| Interaction | UBAP2L interactions | 3.31e-04 | 298 | 41 | 5 | int:UBAP2L | |
| Interaction | LHX4 interactions | 3.55e-04 | 166 | 41 | 4 | int:LHX4 | |
| Interaction | AGO2 interactions | 3.59e-04 | 472 | 41 | 6 | int:AGO2 | |
| Interaction | PPP1R2B interactions | 3.62e-04 | 14 | 41 | 2 | int:PPP1R2B | |
| Interaction | GARRE1 interactions | 3.63e-04 | 167 | 41 | 4 | int:GARRE1 | |
| Interaction | CNOT1 interactions | 3.68e-04 | 305 | 41 | 5 | int:CNOT1 | |
| Interaction | ETV4 interactions | 3.73e-04 | 69 | 41 | 3 | int:ETV4 | |
| Interaction | CIC interactions | 3.75e-04 | 673 | 41 | 7 | int:CIC | |
| Interaction | CEP85 interactions | 3.79e-04 | 169 | 41 | 4 | int:CEP85 | |
| Interaction | GATA1 interactions | 3.97e-04 | 171 | 41 | 4 | int:GATA1 | |
| Interaction | PATL1 interactions | 4.52e-04 | 177 | 41 | 4 | int:PATL1 | |
| Interaction | RCOR1 interactions | 4.57e-04 | 494 | 41 | 6 | int:RCOR1 | |
| Interaction | DDX6 interactions | 5.02e-04 | 503 | 41 | 6 | int:DDX6 | |
| Interaction | LHX2 interactions | 5.12e-04 | 183 | 41 | 4 | int:LHX2 | |
| Interaction | AGO1 interactions | 5.12e-04 | 183 | 41 | 4 | int:AGO1 | |
| Interaction | DZIP3 interactions | 5.12e-04 | 183 | 41 | 4 | int:DZIP3 | |
| Interaction | CHD4 interactions | 5.19e-04 | 938 | 41 | 8 | int:CHD4 | |
| Interaction | DTX2 interactions | 5.28e-04 | 330 | 41 | 5 | int:DTX2 | |
| Interaction | CLTB interactions | 5.34e-04 | 185 | 41 | 4 | int:CLTB | |
| Interaction | SECISBP2 interactions | 5.35e-04 | 78 | 41 | 3 | int:SECISBP2 | |
| Interaction | GATA3 interactions | 5.56e-04 | 187 | 41 | 4 | int:GATA3 | |
| Interaction | RPS20 interactions | 5.57e-04 | 513 | 41 | 6 | int:RPS20 | |
| Interaction | HNF1B interactions | 5.90e-04 | 190 | 41 | 4 | int:HNF1B | |
| Interaction | FAM120C interactions | 6.02e-04 | 191 | 41 | 4 | int:FAM120C | |
| Interaction | ZMYND12 interactions | 6.19e-04 | 82 | 41 | 3 | int:ZMYND12 | |
| Interaction | SOX7 interactions | 6.19e-04 | 82 | 41 | 3 | int:SOX7 | |
| Interaction | GOLGA2 interactions | 6.25e-04 | 733 | 41 | 7 | int:GOLGA2 | |
| Interaction | PAX2 interactions | 6.88e-04 | 85 | 41 | 3 | int:PAX2 | |
| Interaction | IRF4 interactions | 6.88e-04 | 85 | 41 | 3 | int:IRF4 | |
| Interaction | GATA2 interactions | 7.02e-04 | 199 | 41 | 4 | int:GATA2 | |
| Interaction | AP2A2 interactions | 7.02e-04 | 199 | 41 | 4 | int:AP2A2 | |
| Cytoband | 10q21.3 | 4.29e-04 | 34 | 41 | 2 | 10q21.3 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.33e-06 | 25 | 29 | 3 | 775 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 5.15e-03 | 67 | 29 | 2 | 519 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | PAXIP1 NCOA6 BMP2K ATXN1 INTS7 UBAP2L DENND4B MARCHF6 ZMYND8 ITPR2 | 1.33e-05 | 1215 | 41 | 10 | M41122 |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.47e-05 | 200 | 41 | 5 | M6247 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.60e-05 | 856 | 41 | 8 | M4500 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | AAK1 PPP1R18 EIF3H ARID1A VEZF1 ATXN1 JMJD1C DENND4B MARCHF6 ITPR2 | 7.66e-05 | 1492 | 41 | 10 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 8.00e-05 | 680 | 41 | 7 | M41089 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 8.21e-05 | 467 | 41 | 6 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 9.99e-05 | 484 | 41 | 6 | MM999 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 1.30e-04 | 11 | 41 | 2 | M1358 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 1.30e-04 | 11 | 41 | 2 | MM569 | |
| Coexpression | GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 1.47e-04 | 171 | 41 | 4 | M6853 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | 1.84e-04 | 778 | 41 | 7 | M17915 | |
| Coexpression | YAGI_AML_WITH_11Q23_REARRANGED | 1.98e-04 | 346 | 41 | 5 | M17123 | |
| Coexpression | BENPORATH_EED_TARGETS | 2.01e-04 | 1059 | 41 | 8 | M7617 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 2.47e-04 | 196 | 41 | 4 | M4928 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 2.52e-04 | 197 | 41 | 4 | M9569 | |
| Coexpression | GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN | 2.62e-04 | 199 | 41 | 4 | M3481 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 2.67e-04 | 200 | 41 | 4 | M9458 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_UP | 2.67e-04 | 200 | 41 | 4 | M6426 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP | 2.67e-04 | 200 | 41 | 4 | M5134 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.67e-04 | 200 | 41 | 4 | M302 | |
| Coexpression | GSE27786_NKCELL_VS_ERYTHROBLAST_UP | 2.67e-04 | 200 | 41 | 4 | M4853 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP | 2.67e-04 | 200 | 41 | 4 | M7879 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_DN | 2.67e-04 | 200 | 41 | 4 | M5525 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP | 2.67e-04 | 200 | 41 | 4 | M9860 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 2.67e-04 | 200 | 41 | 4 | M7532 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 2.67e-04 | 200 | 41 | 4 | M8869 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 2.67e-04 | 200 | 41 | 4 | M9133 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 2.67e-04 | 200 | 41 | 4 | M3830 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 3.00e-04 | 843 | 41 | 7 | M2356 | |
| Coexpression | PHESSE_TARGETS_OF_APC_AND_MBD2_UP | 3.59e-04 | 18 | 41 | 2 | M2201 | |
| Coexpression | PHESSE_TARGETS_OF_APC_AND_MBD2_UP | 4.46e-04 | 20 | 41 | 2 | MM890 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.63e-05 | 166 | 41 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-05 | 179 | 41 | 4 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 182 | 41 | 4 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.44e-05 | 184 | 41 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.59e-05 | 187 | 41 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-05 | 190 | 41 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 192 | 41 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.31e-05 | 199 | 41 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.55e-05 | 195 | 41 | 5 | 1532_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; HL60; HG-U133A | 2.68e-05 | 197 | 41 | 5 | 1991_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 1796_DN | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 7066_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 1862_DN | |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 7058_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; PC3; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 1808_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.88e-05 | 200 | 41 | 5 | 6034_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 2.88e-05 | 200 | 41 | 5 | 1953_DN | |
| Disease | renal cell carcinoma | 2.75e-05 | 42 | 41 | 3 | EFO_0000681 | |
| Disease | household income | 6.21e-05 | 304 | 41 | 5 | EFO_0009695 | |
| Disease | diet measurement | 8.36e-05 | 1049 | 41 | 8 | EFO_0008111 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.23e-04 | 12 | 41 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | age at menarche | 1.60e-04 | 594 | 41 | 6 | EFO_0004703 | |
| Disease | liver volume | 1.96e-04 | 15 | 41 | 2 | EFO_0600048 | |
| Disease | T-Cell Lymphoma | 2.23e-04 | 16 | 41 | 2 | C0079772 | |
| Disease | feeling nervous measurement | 2.43e-04 | 87 | 41 | 3 | EFO_0009597 | |
| Disease | Neurodevelopmental Disorders | 2.96e-04 | 93 | 41 | 3 | C1535926 | |
| Disease | Adenoid Cystic Carcinoma | 3.67e-04 | 100 | 41 | 3 | C0010606 | |
| Disease | Hypermetropia | 4.00e-04 | 103 | 41 | 3 | HP_0000540 | |
| Disease | digestive system infectious disorder | 5.99e-04 | 26 | 41 | 2 | MONDO_0043424 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 5.99e-04 | 26 | 41 | 2 | EFO_0009944 | |
| Disease | cognitive function measurement | 6.94e-04 | 1434 | 41 | 8 | EFO_0008354 | |
| Disease | forced expiratory volume | 7.26e-04 | 789 | 41 | 6 | EFO_0004314 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.08e-03 | 566 | 41 | 5 | EFO_0007660, EFO_0008354 | |
| Disease | mitochondrial DNA measurement | 1.10e-03 | 328 | 41 | 4 | EFO_0006312 | |
| Disease | colon cancer (is_implicated_in) | 1.15e-03 | 36 | 41 | 2 | DOID:219 (is_implicated_in) | |
| Disease | response to platinum based chemotherapy, drug allergy | 1.15e-03 | 36 | 41 | 2 | EFO_0004647, EFO_0009482 | |
| Disease | breast cancer (is_implicated_in) | 1.19e-03 | 150 | 41 | 3 | DOID:1612 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQQKHQYQQRRQQEN | 271 | O15372 | |
| NQQQQQNQHQQPTAP | 371 | Q9BWU1 | |
| QQQQAQTQQFQAVHP | 491 | Q2M2I8 | |
| NAQRIQTLPNQNQSQ | 201 | Q8IX12 | |
| PGHKAEQQQQQQQQQ | 191 | P54253 | |
| RHPHQQQQQQQQQQQ | 456 | Q9NSY1 | |
| QQQQAQQQSPRRVAV | 246 | P43699 | |
| QQQQQQALQSRHHAQ | 286 | Q7Z5J4 | |
| AQQPLQQQQQRNAYT | 946 | Q9NVH2 | |
| NHNRELQNFLRNQNN | 1931 | Q14571 | |
| PQQQQQQQQRHDSYG | 1326 | O14497 | |
| HPFSQQQQQQQQAHP | 446 | Q6ZW49 | |
| QQQQQQQAHPHQFSQ | 451 | Q6ZW49 | |
| HQRQQQNRSQHRNLN | 366 | Q86TB9 | |
| HHHPQQQQQQQQPQQ | 121 | Q14774 | |
| RQAQQQQQQQQGSRP | 971 | Q8IWI9 | |
| PKQNTHQQQQQRSIR | 296 | Q15652 | |
| SDGQRRRQQQQQQQQ | 36 | P54098 | |
| NNNQHARNNNAIPVV | 586 | O60337 | |
| QAQRPQQQRQSQAHQ | 21 | P24043 | |
| QQQRQSQAHQQRGLF | 26 | P24043 | |
| ANRQQHARMQQHQQQ | 441 | Q8IZL2 | |
| QQQQQLQARPPQQHQ | 281 | Q14686 | |
| QQQQQQQHQQPNRAR | 1016 | Q6Y7W6 | |
| QQHQQPNRARNNTHS | 1021 | Q6Y7W6 | |
| QFRQPLRERQQQQQQ | 886 | O75064 | |
| QQNQQQQPQSSQGTR | 846 | Q9ULU4 | |
| HQNRFIRQERQQQQQ | 86 | Q6NYC8 | |
| TQQQPQQFRNDNRQQ | 976 | O95104 | |
| YRRQQQQQQQQPPHH | 56 | Q5T953 | |
| AGQVQQQQQRRHQQG | 56 | Q8TAE6 | |
| RQGQAPEQQQRHNQV | 531 | Q7Z2Y5 | |
| HTNCKQAERPNNQQN | 96 | Q9UPZ6 | |
| QQQQQQQQQRPPHLV | 141 | P20265 | |
| LVQRNRQNEQQNQGP | 251 | Q14188 | |
| HQVQPQQQQLQNRWV | 341 | Q7Z739 | |
| QQQQQQQQQHVTSWP | 346 | Q14119 | |
| QPQNQNQTQHKQRPQ | 16 | Q14157 | |
| QQRQQQQCPPQRAQQ | 6 | Q96PI1 | |
| HQQRLQEQRQQQSGE | 111 | Q92753 | |
| GAAAARRRQQQQQQQ | 96 | Q96EK4 | |
| KRATANNQQPQQQQQ | 86 | Q8NDV7 | |
| HQQQQEQQNSQRLGQ | 281 | O60663 | |
| PQERNPQQNMNIRQH | 346 | Q9UL68 |